Peer review reports
From: MZ1, a BRD4 inhibitor, exerted its anti-cancer effects by suppressing SDC1 in glioblastoma
Original Submission | ||
---|---|---|
10 Dec 2023 | Submitted | Original manuscript |
7 Jan 2024 | Reviewed | Reviewer Report - Bhrigu Kumar Das |
16 Jan 2024 | Reviewed | Reviewer Report |
24 Jan 2024 | Author responded | Author comments - Jian Pan |
Resubmission - Version 2 | ||
24 Jan 2024 | Submitted | Manuscript version 2 |
1 Feb 2024 | Reviewed | Reviewer Report |
3 Feb 2024 | Reviewed | Reviewer Report - Bhrigu Kumar Das |
Resubmission - Version 3 | ||
Submitted | Manuscript version 3 | |
Publishing | ||
6 Feb 2024 | Editorially accepted | |
16 Feb 2024 | Article published | 10.1186/s12885-024-11966-8 |